Scroll »
Finding the right DIY project is kind of like finding the right treatment for you—it’s unique to your experience and based on the things that matter most in your life.
For Troy, something that matters to him is reading with his grandsons. So when he got the opportunity to build a Little Free Library® for them with HGTV’s Brian and Mika Kleinschmidt, he couldn’t resist. See how VYVGART Hytrulo helped improve Troy’s arm and leg function, which he’s retained, as he tackles this DIY activity.
The people featured above are paid spokespeople taking VYVGART Hytrulo.
The brands listed are the trademarks of their respective owners.
Little Free Library® and its logo are registered trademarks of Little Free Library, a 501(c)(3) nonprofit organization, and are used with permission.
Cedar Roof library plans, from How to Build Your Very Own Little Free Library ©2025 Quarto Publishing Group USA Inc., used with permission.
Whether you’re considering VYVGART Hytrulo or already on treatment, My VYVGART Hytrulo Journey provides an opportunity to connect with a mentor—someone who understands CIDP and has firsthand experience with VYVGART Hytrulo.
See the safety and effectiveness results of VYVGART Hytrulo from the largest clinical study in CIDP history.
Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
It is not known if VYVGART HYTRULO is safe and effective in children.
VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.
Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
It is not known if VYVGART HYTRULO is safe and effective in children.
VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.